Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Berliner

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nature Chemistry|March 7, 2018
Evolution of sequence-defined highly functionalized nucleic acid polymersZhen Chen, Phillip A Lichtor, Adrian P Berliner, et al.
Journal of Neuro-Oncology|February 11, 2018
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumorsNathan J Robison, Kee Kiat Yeo, Adrian P Berliner, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nature Chemistry|March 7, 2018
Evolution of sequence-defined highly functionalized nucleic acid polymersZhen Chen, Phillip A Lichtor, Adrian P Berliner, et al.
Journal of Neuro-Oncology|February 11, 2018
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumorsNathan J Robison, Kee Kiat Yeo, Adrian P Berliner, et al.
Pageof 1